David earned a PhD in Biological Sciences from Columbia University in New York, NY, where he studied how Drosophila ovarian adult stem cells respond to cell signaling pathway manipulations. This work helped to redefine the organizational principles underlying adult stem cell growth models. He is currently a Science Writer, as part of the BioNews Services writing team.
The first healthy volunteer has been dosed in an Australian Phase 1 clinical trial investigating IMU-856, a potential novel treatment for ... Read more
The European Commission has approved an under-the-skin injectable formulation of Remsima (infliximab) to treat patients with the two most common forms ... Read more
The Bruce and Cynthia Sherman Charitable Foundation is now accepting nominations for the 2020 Sherman Prizes, which recognize individuals working toward ... Read more
The U.K. National Institute for Health and Care Excellence (NICE) has recommended the use of Stelara (ustekinumab) to treat patients with ... Read more
